We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Technique for Identifying ‘Small’ Molecules Could Accelerate Drug Discovery & Manufacturing

News   Nov 29, 2018 | Original story from UCLA

 
Technique for Identifying ‘Small’ Molecules Could Accelerate Drug Discovery & Manufacturing

The technique, developed by a UCLA-led team of scientists, can identify specific organic molecules from a mixture of multiple compounds, something most analytical methods cannot do. Credit: Christopher Jones, ACS Central Science

 
 
 

RELATED ARTICLES

Targeting a Protease To Treat Inflammatory Bowel Disease

News

The protease MT1-MMP could be a possible future target for drugs to treat inflammatory bowel disease (IBD) according to a new study.

READ MORE

A Nice Reactive Ring to It

News

Researchers have introduced a new synthetic process for producing an important family of carbon-based molecules known as γ-aryl-β-ketoesters. These molecules are used in the production of many vital pharmaceuticals.

READ MORE

Ribosome-based Treatments: A Sought After Therapy Option for Orphan Diseases?

News

Recently, Urania Therapeutics announced that it has successfully raised €3.53M ($3.89M) in seed funding to unlock the therapeutic potential of ribosome-based treatments. We spoke with Jean-Paul Renaud, President and CSO of Urania Therapeutics, to learn more about the mechanisms of readthrough compounds and how the company hopes to provide treatment solutions for orphan diseases.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE